NLRP3 and breast carcinoma: NLRP3 inflammasomes mediate both suppressions of apoptosis and progression of the cell cycle by leptin-dependent ROS production in breast cancer, which is mediated via estrogen receptor alpha (ERα)/reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase signaling (46).